- Medicine Information and Evidence for Policy > Information and Publications
- Medicine Information and Evidence for Policy > Medicines Policy
(2003; 20 pages) [French] [Spanish]
Good manufacturing practice in China: rapid progress
In the Annual Report 2001: Essential Drugs and Medicines Policy, the number of pharmaceutical manufacturers that would be compliant with good manufacturing practice (GMP) by the end of 2002 was estimated at 1200. In fact, by the end of 2002, 1600 pharmaceutical manufacturers were compliant with GMP. This rapid progress is due to China's concerted effort, with WHO assistance, to organize GMP training and to translate WHO's GMP basic training modules into Chinese (see: http://www.who.int/medicines/organization/qsm/activities/qualityassurance/gmp/trainingmodules/whobasictraining modulesgmp.htm). An article by K. Morimoto et al. entitled Promoting GMP implementation: developing training materials for the international audience, will appear in Quality Assurance: Good Practice, Regulation, and Law, 2003, 10(1).